Global Blood Plasma Derivatives Market Size study & Forecast, by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others), by Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand'S Disease, Other Application), by End User (Hospitals, Clinics, Others) and Regional Analysis, 2023-2030
Global Blood Plasma Derivatives Market is valued at approximately USD 43650.9 million in 2022 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 2023-2030. The blood plasma derivatives market refers to the segment of the pharmaceutical industry that involves the collection, processing, and commercialization of therapeutic products derived from human blood plasma. These derivatives are obtained through a complex manufacturing process that includes fractionation, purification, and sterilization to isolate and extract specific proteins, antibodies, and other bioactive substances found in blood plasma. These products are used for various therapeutic purposes, including treating immune disorders, coagulation disorders, and certain genetic diseases. The blood plasma derivatives market is being driven by factors such as the increasing geriatric population that are more susceptible to developing infectious diseases and the Increasing prevalence of chronic diseases.
Blood plasma derivatives play a crucial role in the treatment of various medical conditions and provide therapeutic options for patients with immune deficiencies, coagulation disorders, and other diseases. According to the International Diabetes Federation (IDF), diabetes can afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, geriatric, and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050.Thus, the growing prevalence of chronic disease and the growing aging population fueling the growth of the market. In addition, increasing awareness & diagnosis of rare diseases and technological advancements in plasma fractionation. However, strict regulatory compliances may hinder the growth of the market throughout the forecast period of 2023-2030.
The key regions considered for the Global Blood Plasma Derivatives Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the well-developed healthcare infrastructure, including hospitals, clinics, and diagnostic centers. These facilities have advanced capabilities for blood plasma collection, processing, and manufacturing of derivatives, leading to a robust market for plasma-based products. North America is also considered the fastest growing region during the forecasted period due to the high demand for plasma-derived products and reimbursement systems.
Major market player included in this report are:
Baxter International Inc.
Bayer AG
CSL Limited
Fusion Health Care Pvt. Ltd.
Grifols S.A.
Kedrion S.p.A.
LFB S.A.
Octapharma AG
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Recent Developments in the Market:
In March 2020, Grifols collaborates with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA) and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this specific plasma into a hyperimmune globulin and support the necessary preclinical and clinical studies to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to treat COVID-19 disease. Grifols will volunteer its expertise and resources in the areas of plasma collection using its network of FDA-approved plasma donor centers; test and qualify donors in conjunction with other health agencies; process plasma into hyperimmune globulin in its purpose-built facility in Clayton, North Carolina, for the isolated processing of immune globulins to treat emerging infectious diseases.
Global Blood Plasma Derivatives Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered -, Type, Application, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
By Application:
Hemophilia
Hypogammaglobulinemia
Immunodeficiency Diseases
Von Willebrand'S Disease
Other Application
By End User:
Hospitals
Clinics
Others End User
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Blood plasma derivatives play a crucial role in the treatment of various medical conditions and provide therapeutic options for patients with immune deficiencies, coagulation disorders, and other diseases. According to the International Diabetes Federation (IDF), diabetes can afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, geriatric, and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050.Thus, the growing prevalence of chronic disease and the growing aging population fueling the growth of the market. In addition, increasing awareness & diagnosis of rare diseases and technological advancements in plasma fractionation. However, strict regulatory compliances may hinder the growth of the market throughout the forecast period of 2023-2030.
The key regions considered for the Global Blood Plasma Derivatives Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the well-developed healthcare infrastructure, including hospitals, clinics, and diagnostic centers. These facilities have advanced capabilities for blood plasma collection, processing, and manufacturing of derivatives, leading to a robust market for plasma-based products. North America is also considered the fastest growing region during the forecasted period due to the high demand for plasma-derived products and reimbursement systems.
Major market player included in this report are:
Baxter International Inc.
Bayer AG
CSL Limited
Fusion Health Care Pvt. Ltd.
Grifols S.A.
Kedrion S.p.A.
LFB S.A.
Octapharma AG
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Recent Developments in the Market:
In March 2020, Grifols collaborates with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA) and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this specific plasma into a hyperimmune globulin and support the necessary preclinical and clinical studies to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to treat COVID-19 disease. Grifols will volunteer its expertise and resources in the areas of plasma collection using its network of FDA-approved plasma donor centers; test and qualify donors in conjunction with other health agencies; process plasma into hyperimmune globulin in its purpose-built facility in Clayton, North Carolina, for the isolated processing of immune globulins to treat emerging infectious diseases.
Global Blood Plasma Derivatives Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered -, Type, Application, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
By Application:
Hemophilia
Hypogammaglobulinemia
Immunodeficiency Diseases
Von Willebrand'S Disease
Other Application
By End User:
Hospitals
Clinics
Others End User
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Blood Plasma Derivatives Market, by Region, 2020-2030 (USD Million)
1.2.2. Blood Plasma Derivatives Market, by Type, 2020-2030 (USD Million)
1.2.3. Blood Plasma Derivatives Market, by Application, 2020-2030 (USD Million)
1.2.4. Blood Plasma Derivatives Market, by End User, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BLOOD PLASMA DERIVATIVES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BLOOD PLASMA DERIVATIVES MARKET DYNAMICS
3.1. Blood Plasma DerivativesMarket Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of chronic diseases
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Strict regulatory compliances
3.1.3. Market Opportunities
3.1.3.1. Increasing awareness & diagnosis of rare diseases
3.1.3.2. Technological advancements in plasma fractionation
CHAPTER 4. GLOBAL BLOOD PLASMA DERIVATIVESMARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BLOOD PLASMA DERIVATIVESMARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Blood Plasma DerivativesMarket by Type, Performance - Potential Analysis
5.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by Type 2020-2030 (USD Million)
5.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
5.4.1. Albumin
5.4.2. Factor VIII
5.4.3. Factor IX
5.4.4. Immunoglobulin
5.4.5. Hyperimmune Globulin
5.4.6. Others
CHAPTER 6. GLOBAL BLOOD PLASMA DERIVATIVESMARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Blood Plasma DerivativesMarket by Application, Performance - Potential Analysis
6.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
6.4.1. Hemophilia
6.4.2. Hypogammaglobulinemia
6.4.3. Immunodeficiency Diseases
6.4.4. Von Willebrand'S Disease
6.4.5. Other Application
CHAPTER 7. GLOBAL BLOOD PLASMA DERIVATIVESMARKET, BY END USER
7.1. Market Snapshot
7.2. Global Blood Plasma DerivativesMarket by End User, Performance - Potential Analysis
7.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by End User 2020-2030 (USD Million)
7.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Others End User
CHAPTER 8. GLOBAL BLOOD PLASMA DERIVATIVESMARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Blood Plasma DerivativesMarket, Regional Market Snapshot
8.4. North America Blood Plasma DerivativesMarket
8.4.1. U.S. Blood Plasma DerivativesMarket
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Blood Plasma DerivativesMarket
8.5. Europe Blood Plasma DerivativesMarket Snapshot
8.5.1. U.K. Blood Plasma DerivativesMarket
8.5.2. Germany Blood Plasma DerivativesMarket
8.5.3. France Blood Plasma DerivativesMarket
8.5.4. Spain Blood Plasma DerivativesMarket
8.5.5. Italy Blood Plasma DerivativesMarket
8.5.6. Rest of Europe Blood Plasma DerivativesMarket
8.6. Asia-Pacific Blood Plasma DerivativesMarket Snapshot
8.6.1. China Blood Plasma DerivativesMarket
8.6.2. India Blood Plasma DerivativesMarket
8.6.3. Japan Blood Plasma DerivativesMarket
8.6.4. Australia Blood Plasma DerivativesMarket
8.6.5. South Korea Blood Plasma DerivativesMarket
8.6.6. Rest of Asia Pacific Blood Plasma DerivativesMarket
8.7. Latin America Blood Plasma DerivativesMarket Snapshot
8.7.1. Brazil Blood Plasma DerivativesMarket
8.7.2. Mexico Blood Plasma DerivativesMarket
8.8. Middle East & Africa Blood Plasma DerivativesMarket
8.8.1. Saudi Arabia Blood Plasma DerivativesMarket
8.8.2. South Africa Blood Plasma DerivativesMarket
8.8.3. Rest of Middle East & Africa Blood Plasma DerivativesMarket
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Baxter International Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bayer AG
9.3.3. CSL Limited
9.3.4. Fusion Health Care Pvt. Ltd.
9.3.5. Grifols S.A.
9.3.6. Kedrion S.p.A.
9.3.7. LFB S.A.
9.3.8. Octapharma AG
9.3.9. Sanofi S.A.
9.3.10. Takeda Pharmaceutical Company Limited
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Blood Plasma Derivatives Market, by Region, 2020-2030 (USD Million)
1.2.2. Blood Plasma Derivatives Market, by Type, 2020-2030 (USD Million)
1.2.3. Blood Plasma Derivatives Market, by Application, 2020-2030 (USD Million)
1.2.4. Blood Plasma Derivatives Market, by End User, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BLOOD PLASMA DERIVATIVES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BLOOD PLASMA DERIVATIVES MARKET DYNAMICS
3.1. Blood Plasma DerivativesMarket Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of chronic diseases
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Strict regulatory compliances
3.1.3. Market Opportunities
3.1.3.1. Increasing awareness & diagnosis of rare diseases
3.1.3.2. Technological advancements in plasma fractionation
CHAPTER 4. GLOBAL BLOOD PLASMA DERIVATIVESMARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BLOOD PLASMA DERIVATIVESMARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Blood Plasma DerivativesMarket by Type, Performance - Potential Analysis
5.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by Type 2020-2030 (USD Million)
5.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
5.4.1. Albumin
5.4.2. Factor VIII
5.4.3. Factor IX
5.4.4. Immunoglobulin
5.4.5. Hyperimmune Globulin
5.4.6. Others
CHAPTER 6. GLOBAL BLOOD PLASMA DERIVATIVESMARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Blood Plasma DerivativesMarket by Application, Performance - Potential Analysis
6.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
6.4.1. Hemophilia
6.4.2. Hypogammaglobulinemia
6.4.3. Immunodeficiency Diseases
6.4.4. Von Willebrand'S Disease
6.4.5. Other Application
CHAPTER 7. GLOBAL BLOOD PLASMA DERIVATIVESMARKET, BY END USER
7.1. Market Snapshot
7.2. Global Blood Plasma DerivativesMarket by End User, Performance - Potential Analysis
7.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by End User 2020-2030 (USD Million)
7.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Others End User
CHAPTER 8. GLOBAL BLOOD PLASMA DERIVATIVESMARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Blood Plasma DerivativesMarket, Regional Market Snapshot
8.4. North America Blood Plasma DerivativesMarket
8.4.1. U.S. Blood Plasma DerivativesMarket
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Blood Plasma DerivativesMarket
8.5. Europe Blood Plasma DerivativesMarket Snapshot
8.5.1. U.K. Blood Plasma DerivativesMarket
8.5.2. Germany Blood Plasma DerivativesMarket
8.5.3. France Blood Plasma DerivativesMarket
8.5.4. Spain Blood Plasma DerivativesMarket
8.5.5. Italy Blood Plasma DerivativesMarket
8.5.6. Rest of Europe Blood Plasma DerivativesMarket
8.6. Asia-Pacific Blood Plasma DerivativesMarket Snapshot
8.6.1. China Blood Plasma DerivativesMarket
8.6.2. India Blood Plasma DerivativesMarket
8.6.3. Japan Blood Plasma DerivativesMarket
8.6.4. Australia Blood Plasma DerivativesMarket
8.6.5. South Korea Blood Plasma DerivativesMarket
8.6.6. Rest of Asia Pacific Blood Plasma DerivativesMarket
8.7. Latin America Blood Plasma DerivativesMarket Snapshot
8.7.1. Brazil Blood Plasma DerivativesMarket
8.7.2. Mexico Blood Plasma DerivativesMarket
8.8. Middle East & Africa Blood Plasma DerivativesMarket
8.8.1. Saudi Arabia Blood Plasma DerivativesMarket
8.8.2. South Africa Blood Plasma DerivativesMarket
8.8.3. Rest of Middle East & Africa Blood Plasma DerivativesMarket
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Baxter International Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bayer AG
9.3.3. CSL Limited
9.3.4. Fusion Health Care Pvt. Ltd.
9.3.5. Grifols S.A.
9.3.6. Kedrion S.p.A.
9.3.7. LFB S.A.
9.3.8. Octapharma AG
9.3.9. Sanofi S.A.
9.3.10. Takeda Pharmaceutical Company Limited
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Blood Plasma DerivativesMarket, report scope
TABLE 2. Global Blood Plasma DerivativesMarket estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Blood Plasma DerivativesMarket estimates & forecasts by Type 2020-2030 (USD Million)
TABLE 4. Global Blood Plasma DerivativesMarket estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 5. Global Blood Plasma DerivativesMarket estimates & forecasts by End User 2020-2030 (USD Million)
TABLE 6. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. U.S. Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. Canada Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 20. Canada Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. Canada Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. UK Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 23. UK Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. UK Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. Germany Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 26. Germany Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. Germany Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. France Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 29. France Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. France Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. Italy Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 32. Italy Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Italy Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Spain Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 35. Spain Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. Spain Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. RoE Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 38. RoE Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. RoE Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. China Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 41. China Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. China Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. India Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 44. India Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. India Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. Japan Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 47. Japan Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. Japan Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. South Korea Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 50. South Korea Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. South Korea Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. Australia Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 53. Australia Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. Australia Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. RoAPAC Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 56. RoAPAC Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. RoAPAC Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. Brazil Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 59. Brazil Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Brazil Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Mexico Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 62. Mexico Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. Mexico Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. RoLA Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 65. RoLA Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. RoLA Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. Saudi Arabia Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 68. South Africa Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. RoMEA Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Blood Plasma DerivativesMarket
TABLE 71. List of primary sources, used in the study of global Blood Plasma DerivativesMarket
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Blood Plasma DerivativesMarket, report scope
TABLE 2. Global Blood Plasma DerivativesMarket estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Blood Plasma DerivativesMarket estimates & forecasts by Type 2020-2030 (USD Million)
TABLE 4. Global Blood Plasma DerivativesMarket estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 5. Global Blood Plasma DerivativesMarket estimates & forecasts by End User 2020-2030 (USD Million)
TABLE 6. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Blood Plasma DerivativesMarket by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Blood Plasma DerivativesMarket by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. U.S. Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. Canada Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 20. Canada Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. Canada Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. UK Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 23. UK Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. UK Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. Germany Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 26. Germany Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. Germany Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. France Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 29. France Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. France Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. Italy Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 32. Italy Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Italy Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Spain Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 35. Spain Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. Spain Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. RoE Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 38. RoE Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. RoE Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. China Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 41. China Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. China Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. India Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 44. India Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. India Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. Japan Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 47. Japan Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. Japan Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. South Korea Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 50. South Korea Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. South Korea Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. Australia Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 53. Australia Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. Australia Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. RoAPAC Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 56. RoAPAC Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. RoAPAC Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. Brazil Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 59. Brazil Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Brazil Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Mexico Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 62. Mexico Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. Mexico Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. RoLA Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 65. RoLA Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. RoLA Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. Saudi Arabia Blood Plasma DerivativesMarket estimates & forecasts, 2020-2030 (USD Million)
TABLE 68. South Africa Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. RoMEA Blood Plasma DerivativesMarket estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Blood Plasma DerivativesMarket
TABLE 71. List of primary sources, used in the study of global Blood Plasma DerivativesMarket
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Blood Plasma DerivativesMarket, research methodology
FIG 2. Global Blood Plasma DerivativesMarket, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Blood Plasma DerivativesMarket, key trends 2022
FIG 5. Global Blood Plasma DerivativesMarket, growth prospects 2023-2030
FIG 6. Global Blood Plasma DerivativesMarket, porters 5 force model
FIG 7. Global Blood Plasma DerivativesMarket, pest analysis
FIG 8. Global Blood Plasma DerivativesMarket, value chain analysis
FIG 9. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 10. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 11. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 12. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 13. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 14. Global Blood Plasma DerivativesMarket, regional snapshot 2020 & 2030
FIG 15. North America Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
FIG 16. Europe Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
FIG 17. Asia pacific Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
FIG 18. Latin America Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Blood Plasma DerivativesMarket, research methodology
FIG 2. Global Blood Plasma DerivativesMarket, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Blood Plasma DerivativesMarket, key trends 2022
FIG 5. Global Blood Plasma DerivativesMarket, growth prospects 2023-2030
FIG 6. Global Blood Plasma DerivativesMarket, porters 5 force model
FIG 7. Global Blood Plasma DerivativesMarket, pest analysis
FIG 8. Global Blood Plasma DerivativesMarket, value chain analysis
FIG 9. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 10. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 11. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 12. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 13. Global Blood Plasma DerivativesMarket by segment, 2020 & 2030 (USD Million)
FIG 14. Global Blood Plasma DerivativesMarket, regional snapshot 2020 & 2030
FIG 15. North America Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
FIG 16. Europe Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
FIG 17. Asia pacific Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
FIG 18. Latin America Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Blood Plasma DerivativesMarket 2020 & 2030 (USD Million)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
